Venus Concept Inc. VERO

Competitive advantage analysis · healthcare

Medical Devices & Diagnostics
Overall moat score
51/100
Moderate

Ranked against 159 peers in Medical Devices

About Venus Concept Inc.

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus … Full VERO analysis →

Key strengths

  • Stable Gross Margin Profile Gross margin stability is strong (score 0.80). Low volatility confirms durable consumable pricing.

Key risks

  • Weak Capital Return Profile Capital return quality is below peers (score 0.28). Low ROIC raises questions about M&A discipline and pipeline ROI.
  • Operating Margin Compression Operating margin trend is negative (score 0.28). Sustained compression would reduce the commercial moat.

The dashed ring is the peer median. Defense scores are percentile ranks against peers, so 50 is roughly the typical company in this group.

Upgrade to unlock the signals and evidence behind each defense.

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Moderate
72
Premium

Signals, strengths and risks for Pricing Power & Consumable Moat

Premium

Signals, strengths and risks for R&D Pipeline & Capital Returns

Premium

Signals, strengths and risks for FCF Quality & Cash Conversion

Premium

Signals, strengths and risks for Commercial Execution

Premium

Signals, strengths and risks for Capital Structure & Resilience

Premium

Signals, strengths and risks for Growth Durability

Where VERO ranks in Medical Devices

Venus Concept Inc. ranks #67 of 160 scored companies in Medical Devices by moat score — the top 42%. The widest moat in the group is iRadimed Corporation (IRMD) at 83/100.

# Company Moat score Rating
63 Cytosorbents Corporation CTSO 52/100 Moderate
64 Inogen, Inc INGN 52/100 Moderate
65 TELA Bio, Inc. TELA 52/100 Moderate
66 electroCore, Inc. ECOR 51/100 Moderate
67 Venus Concept Inc. VERO 51/100 Moderate
68 Aethlon Medical, Inc. AEMD 51/100 Moderate
69 Apyx Medical Corporation APYX 51/100 Moderate
70 Cytek Biosciences, Inc. CTKB 50/100 Moderate
71 Avita Medical, Inc. RCEL 50/100 Moderate

See every Medical Devices & Diagnostics company ranked by moat score →

How VERO scores on the Medical Devices & Diagnostics defenses

Pricing Power & Consumable Moat

Score 72 · 25% of the moat score

In MedTech, pricing power is rarely about the machine — it is about what the machine consumes.

R&D Pipeline & Capital Returns

Score 35 · 20% of the moat score

Research spending is how a device company keeps its installed base current, but spending alone proves nothing.

FCF Quality & Cash Conversion

Score 52 · 20% of the moat score

MedTech companies grow by acquisition, and the resulting intangible amortisation depresses reported earnings without consuming any cash.

Commercial Execution

Score 41 · 15% of the moat score

Devices are sold into hospitals and labs through committees, tenders and long qualification cycles, which makes the sales organisation expensive and hard to replicate.

Capital Structure & Resilience

Score 52 · 12% of the moat score

Serial acquirers carry debt, and the question is whether the cash flows underneath it are dependable enough to service it through a downturn.

Growth Durability

Score 43 · 8% of the moat score

Growth durability separates an expanding installed base from a good product cycle.

How each Medical Devices & Diagnostics defense is measured, in full →

Understanding VERO's moat

What is Venus Concept Inc.'s moat score?

Venus Concept Inc. (VERO) scores 51 out of 100 on the StatsAlpha Moat Map, which rates its competitive advantage as moderate. It ranks #67 of 160 scored companies in Medical Devices, the top 42%. The score is a weighted composite of 6 competitive defenses, each measured against industry peers of 159 companies in Medical Devices. Its strongest defense is Pricing Power & Consumable Moat (72/100) and its weakest is R&D Pipeline & Capital Returns (35/100).

How does Venus Concept Inc. compare with other Medical Devices companies?

Venus Concept Inc. ranks #67 of 160 scored companies in Medical Devices by moat score. The widest moat in Medical Devices is iRadimed Corporation (IRMD) at 83/100. The companies ranked closest are electroCore, Inc. (ECOR) at 51 just above it and Aethlon Medical, Inc. (AEMD) at 51 just below it.

How is the moat score calculated?

Each company is scored with an industry-specific template — Medical Devices & Diagnostics in this case, chosen because the defenses that matter to a bank are not the ones that matter to a software company. Every defense combines several financial signals, and each signal is measured as a percentile against a peer group of 159 companies in Medical Devices. The defenses are then weighted to produce the overall score out of 100.

Why is Venus Concept Inc. scored with the Medical Devices & Diagnostics template?

Medical device and diagnostics companies place an instrument once and then sell the consumables, reagents and service that instrument needs for the next decade. The economics are a razor-and-blade model wrapped in regulatory approval and clinician habit, so the MedTech template scores the durability of that installed base rather than the size of any single product launch.

Which competitive defenses are measured for Venus Concept Inc.?

The Medical Devices & Diagnostics template measures 6 defenses, and VERO scores: Pricing Power & Consumable Moat (72), R&D Pipeline & Capital Returns (35), FCF Quality & Cash Conversion (52), Commercial Execution (41), Capital Structure & Resilience (52), Growth Durability (43). Each is scored independently as a percentile against peers, so a company can be strong on one and weak on another — the overall score reflects how those defenses are weighted for this industry.

Send Feedback
Please select a category.
0/1000